Bicara Therapeutics (BCAX) Stock Chart & Stock Price History $11.90 -0.04 (-0.34%) Closing price 04:00 PM EasternExtended Trading$11.90 -0.01 (-0.04%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Bicara Therapeutics Stock Price Performance The Bicara Therapeutics (BCAX) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 31.69%. In the past month, the stock has increased 13.01%, reflecting recent market activity. As of the latest close, Bicara Therapeutics traded at $11.94 with a market cap of $651.48 million and volume of 189,264 shares. Receive BCAX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bicara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-0.08%1 Month Performance+13.01%3 Month Performance+20.20%Year-To-Date Performance-31.69% BCAX Stock Chart for Tuesday, September, 2, 2025 BCAX Chart by TradingView Bicara Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/01/2025$11.94$11.94$12.01$11.60189,264 shs$651.48 million08/29/2025$11.91$11.94+0.25%$12.01$11.60189,264 shs$651.48 million08/28/2025$12.02$11.91-0.92%$12.30$11.87244,362 shs$649.81 million08/27/2025$12.04$12.02-0.17%$12.25$11.97321,407 shs$655.81 million08/26/2025$11.32$12.04+6.36%$12.13$11.36332,393 shs$656.94 million08/25/2025$11.84$11.32-4.39%$11.84$11.22139,871 shs$617.62 million08/22/2025$11.63$11.84+1.81%$12.23$11.53267,833 shs$645.99 million08/21/2025$10.96$11.63+6.11%$11.72$10.64351,611 shs$634.53 million08/20/2025$11.51$10.96-4.78%$11.47$10.79541,222 shs$598.01 million08/19/2025$11.47$11.51+0.35%$11.85$11.32227,636 shs$627.99 million Get the Latest News and Ratings for BCAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bicara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/18/2025$11.64$11.47-1.46%$11.96$11.46172,846 shs$625.80 million08/15/2025$11.41$11.64+2.02%$11.69$11.20184,203 shs$635.08 million08/14/2025$11.33$11.41+0.71%$11.55$10.85368,592 shs$622.26 million08/13/2025$10.47$11.33+8.21%$11.45$10.58275,938 shs$617.94 million08/12/2025$9.99$10.47+4.80%$10.77$9.67471,042 shs$571.03 million08/11/2025$10.20$9.99-2.06%$10.20$9.57300,019 shs$544.86 million08/08/2025$10.20$10.20$10.31$9.91194,114 shs$556.31 million08/07/2025$10.44$10.20-2.30%$10.41$9.83238,403 shs$556.27 million08/06/2025$11.36$10.44-8.10%$11.51$10.22259,998 shs$569.40 million08/05/2025$11.12$11.36+2.16%$11.41$11.03243,506 shs$619.57 million08/04/2025$10.53$11.12+5.60%$11.13$10.40541,413 shs$606.44 million08/01/2025$11.11$10.53-5.22%$11.17$10.50409,857 shs$574.26 million Related Companies CPRX Stock Chart ALVO Stock Chart KNSA Stock Chart OGN Stock Chart TARS Stock Chart CNTA Stock Chart DNLI Stock Chart AGIO Stock Chart IDYA Stock Chart IBRX Stock Chart Receive BCAX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bicara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BCAX) was last updated on 9/2/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bicara Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bicara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.